期刊文献+

冠心病及其危险因素与血浆脂蛋白相关磷脂酶A_2变化的关系 被引量:9

下载PDF
导出
摘要 目的:探讨冠心病及其危险因素与血浆脂蛋白相关磷脂酶A2(Lp-PLA2)水平的关系。方法:测定92例冠心病患者和61例对照组的血浆Lp-PLA2、总胆固醇、三酰甘油、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)水平并进行比较;同时调查年龄、性别、高血压史、糖尿病史、高脂血症史、吸烟史等危险因素,分析它们与Lp-PLA2的关系。结果:与对照组相比,冠心病患者血浆Lp-PLA2显著增高(P<0.01);男性及高脂血症冠心病患者的Lp-PLA2明显高于女性和无高脂血症冠心病患者(P均<0.05);相关分析显示,血浆Lp-PLA2水平与总胆固醇、LDL-C呈正相关,与HDL-C呈负相关,而与年龄、高血压、糖尿病、吸烟及三酰甘油无关;多元回归分析显示,调整其他危险因素后,Lp-PLA2仍与冠心病发病独立相关。结论:冠心病患者的血浆Lp-PLA2水平显著增高,是冠心病的独立危险因子。
出处 《江苏大学学报(医学版)》 CAS 2015年第4期360-362,共3页 Journal of Jiangsu University:Medicine Edition
  • 相关文献

参考文献13

  • 1汪俊军.脂蛋白(a)相连的脂蛋白相关磷脂酶A_2在动脉粥样硬化中的作用[J].医学研究生学报,2009,22(8):785-788. 被引量:12
  • 2高应东,夏永祥,张瑞生,彭怀燕,李红卫,欧阳茂.血浆ⅡA分泌型磷脂酶A_2与冠心病相关性研究[J].中国误诊学杂志,2008,8(6):1275-1277. 被引量:6
  • 3王旋,程龙献,崔天盆,张红梅,何美安,廖玉华,邬堂春.血清淀粉样蛋白A与冠心病及冠心病危险因素的关系[J].临床心血管病杂志,2004,20(12):745-747. 被引量:15
  • 4Yimeng Du,Fengtao Wei,Zhaoqiang Dong,Junni Liu,Weidong Jiang,Qinghua Lu.Prognostic Value of Serum LP-PLA2 and hs-CRP in Unstable Atherosclerotic Plaques[J]. Clinical and Experimental Hypertension . 2011 (2)
  • 5Hok-Hay S. Oei,Irene M. van der Meer,Albert Hofman,Peter J. Koudstaal,Theo Stijnen,Monique M.B. Breteler,Jacqueline C.M. Witteman.Lipoprotein-Associated Phospholipase A2 Activity Is Associated With Risk of Coronary Heart Disease and Ischemic Stroke: The Rotterdam Study[J]. Circulation . 2005 (5)
  • 6Wolfgang Koenig,Natalie Khuseyinova,Hannelore L?wel,Gerlinde Trischler,Christa Meisinger.Lipoprotein-Associated Phospholipase A2 Adds to Risk Prediction of Incident Coronary Events by C-Reactive Protein in Apparently Healthy Middle-Aged Men From the General Population: Results From the 14-Year Follow-Up of a Large Cohort From Southern Germany[J]. Circulation . 2004 (14)
  • 7Christie M. Ballantyne,Ron C. Hoogeveen,Heejung Bang,Josef Coresh,Aaron R. Folsom,Gerardo Heiss,A. Richey Sharrett.Lipoprotein-Associated Phospholipase A2, High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study[J]. Circulation: Journal of the American Heart Association . 2004 (7)
  • 8Gavin J Blake,Nisha Dada,Jonathan C Fox,JoAnn E Manson,Paul M Ridker.A prospective evaluation of lipoprotein-associated phospholipase A 2 levels and the risk of future cardiovascular events in women[J]. Journal of the American College of Cardiology . 2001 (5)
  • 9Rosenson Robert S,Hurt-Camejo Eva.Phospholipase A2 enzymes and the risk of atherosclerosis. European Heart Journal . 2012
  • 10LIU Chuan-fen,QIN Li,REN Jing-yi,CHEN Hong,WANG Wei-min,LIU Jian,SONG Jun-xian,LI Li-jun.Elevated plasma lipoprotein-associated phospholipase A2 activity is associated with plaque rupture in patients with coronary artery disease[J].Chinese Medical Journal,2011(16):2469-2473. 被引量:27

二级参考文献75

  • 1汪俊军,李雯,刘恋,周毓,张春妮,范乐明.氧化低密度脂蛋白循环免疫复合物诱导巨噬细胞胆固醇酯蓄积[J].医学研究生学报,2005,18(3):193-195. 被引量:17
  • 2汪俊军,顾振华,张春妮,范乐明.脂蛋白(a)氧化和自身免疫与动脉粥样硬化的关系[J].医学研究生学报,2005,18(8):740-742. 被引量:22
  • 3Hobbs HH, White AL. Lipoprotein: intrigues and insights [ J ]. Curr Opin Lipidol, 1999, 10(3) :225-236.
  • 43Zhuang YY, Li J J, Wang JJ. Apolipoprotein (a) phenotypes in cardio-cerebrovasculor diseases [ J]. Chem Phys Lipid, 1994, 67-68 : 293-297.
  • 5Takami S, Yamashita S, Kihara S, et al. Lipoprotein (a) enhances the expression of intercellular adhesion molecule-1 in cultured human umbilical vein endothelial cells [ J ]. Circulation, 1998, 97(8) :721-728.
  • 6Klezovitch O, Edelstein C, Scanu AM. Stimulation of interleukin-8 production in human THP-1 macrophages by apolipoprotein (a). Evidence for a critical involvement of elements in its C-terminal domain [ J ]. J Biol Chem, 2001, 276 (50) :46864-46869.
  • 7Tsironis LD. Mitsios JV, Milionis HJ, et al. Effect of lipoprotein(a) on platelet activation induced by platelet-activating factor (PAF) : Role of apolipoprotein (a) and endogenous PAF-acetylhydrolase [ J ]. Cardiovasc Res, 2004, 63 ( 1 ) : 130-138.
  • 8Tselepis AD, Chapman MJ. Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-assoeiated phospholipase A2, platelet activating factor-aeetylhydrolase[ J]. Atheroseler, 2002,3 ( Suppl ) : 57-68.
  • 9Leitinger N. Oxidized phospholipids as modulators of inflammation in atherosclerosis[J]. Curr Opin Lipidol, 2003, 14 (5) : 421-430.
  • 10Tsironis LD, Katsouras CS, Lourida ES, et al. Reduced PAF- acetylhydrolase activity associated with Lp (a) in patients with coronary artery disease [J]. Atherosclerosis, 2004, 177 ( 1 ) : 193-201.

共引文献59

同被引文献82

引证文献9

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部